Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Operating activities
Net loss	$ (268,124)	$ (102,021)
Adjusted for the following items:
Inventory valuation adjustments	36,116
Depreciation and amortization expenses	14,232	10,460
Impairment of assets	58,210
Stock-based compensation expenses	23,404	22,303
Change in fair value of warrant liability	51,275
Loss from equity method investments	4,495	1,837
Change in fair value of contingent consideration		(17,019)
Loss from equity investments measured at fair value	1,272	1,572
Loss from sale of investment	65
Interest on debt securities	(601)
Deferred taxes	(4,013)	(3,987)
Amortization of discount on convertible notes	7,944	7,616
Amortization of transaction costs on Senior Facility	943
Foreign currency loss	5,424
Accretion related to obligations under finance leases	394	138
Issuance costs on registered offering recorded to net loss	3,953
Credit loss expenses	288	520
Provision for sales returns	(188)
Loss on disposal of property and equipment	885	112
Other non-cash items	88	1,755
Changes in non-cash working capital:
Accounts receivable	11,072	(15,019)
Inventory	(25,476)	(73,758)
Prepayments and other current assets	4,263	(54,607)
Accounts payable	(12,544)	38,773
Accrued expenses and other current liabilities	(17,863)	16,539
Net cash used in operating activities	(104,486)	(167,255)
Investing activities
Business combinations, net of cash acquired		(166,086)
Interest receipts on debt securities	146
Investment in joint venture with AB InBev	(2,323)
Change in deposits and other assets	(3,148)	85
Purchases of short-term and other investments		(8,486)
Proceeds from the sale of other investments	437	8,640
Purchases of property and equipment	(39,366)	(50,421)
Proceeds from disposal of property and equipment	2,371
Purchases of intangible assets		(941)
Net cash used in investing activities	(41,883)	(264,844)
Financing activities
Proceeds from at-the-market equity offering, net of costs	75,459	37,445
Proceeds from ABG Profit Participation Arrangement	1,353	3,333
Proceeds from issuance of registered offering, net of issuance costs	85,465
Payment of ABG finance liability	(1,500)
Proceeds from exercise of stock options	6,007	4,885
Payment of obligations under finance lease	(309)	(565)
Payment on the settlement of stock options	(1,144)
Proceeds from issuance of Senior Facility, net of transaction costs	46,395
Repayment of Senior Facility	(1,605)
Net cash provided by financing activities	210,121	45,098
Effect of foreign currency translation on cash and cash equivalents	(5,338)	(95)
Increase (decrease) in cash and cash equivalents	58,414	(387,096)
Cash and cash equivalents, beginning of period	96,791	487,255
Cash and cash equivalents, end of period	$ 155,205	100,159
Investment In ABG [Member]
Investing activities
Investment in ABG Profit Participation Arrangement		(33,333)
S & S Acquisition [Member]
Investing activities
Investment in equity method investees and S&S acquisition		$ (14,302)